Literature DB >> 11812533

DMSO as a vehicle for central injections: tests with feeding elicited by norepinephrine injected into the paraventricular nucleus.

J Ernie Blevins1, B Glenn Stanley, Roger D Reidelberger.   

Abstract

Dimethyl sulfoxide (DMSO) is becoming increasingly popular as a vehicle in studies employing central injections. The aim of the present study was to determine whether the vehicle required for solubilization of substances for central injection [75% DMSO and 25% artificial CSF (aCSF)] would alter the well-characterized stimulatory response to norepinephrine (NE) injected into the paraventricular nucleus (PVN) on short-term food intake. To evaluate its suitability, we compared the effects of repeated unilateral injections of NE dissolved in two different vehicles (100% aCSF or 75% DMSO, 25% aCSF), in separate groups of animals every 48 h over a 30-day period. NE (40 nmol) stimulated food intake by approximately sevenfold compared to either vehicle alone, and the stimulatory effect was similar whether aCSF or 75% DMSO was used as a vehicle. Furthermore, the NE-induced feeding did not vary in magnitude across a series of 13 tests. These results suggest that 75% DMSO is a suitable vehicle for administering NE (and likely other water-insoluble substances)in small volumes of 0.3 microl into specific brain regions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812533     DOI: 10.1016/s0091-3057(01)00659-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  17 in total

1.  Metaplasticity of hypothalamic synapses following in vivo challenge.

Authors:  J Brent Kuzmiski; Quentin J Pittman; Jaideep S Bains
Journal:  Neuron       Date:  2009-06-25       Impact factor: 17.173

2.  Mediatory role of the dopaminergic system through D1 receptor on glycine-induced hypophagia in neonatal broiler-type chickens.

Authors:  Jamal Rahimi; Morteza Zendehdel; Mina Khodadadi
Journal:  Amino Acids       Date:  2021-03-01       Impact factor: 3.520

3.  Intracranial Pharmacotherapy and Pain Assays in Rodents.

Authors:  Erik Martinez; Haocheng Zhou; Jing Wang
Journal:  J Vis Exp       Date:  2019-04-09       Impact factor: 1.355

4.  Acute estradiol protects CA1 neurons from ischemia-induced apoptotic cell death via the PI3K/Akt pathway.

Authors:  Teresa Jover-Mengual; Takahiro Miyawaki; Adrianna Latuszek; Enrique Alborch; R Suzanne Zukin; Anne M Etgen
Journal:  Brain Res       Date:  2010-01-28       Impact factor: 3.252

5.  Hindbrain orexin 1 receptors blunt intake suppression by gastrointestinal nutrients and cholecystokinin in male rats.

Authors:  Diana L Williams; Isabel I Coiduras; Eric M Parise; Calyn B Maske
Journal:  Peptides       Date:  2020-06-21       Impact factor: 3.750

6.  Modulatory function of NMDA glutamate receptor on MC3/MC4 receptors agonist-induced hypophagia in neonatal meat-type chicken.

Authors:  Fariba Ahmadi; Morteza Zendehdel; Vahab Babapour; Negar Panahi; Shahin Hassanpour; Mina Khodadadi
Journal:  Vet Res Commun       Date:  2017-06-06       Impact factor: 2.459

7.  MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia.

Authors:  Teresa Jover-Mengual; R Suzanne Zukin; Anne M Etgen
Journal:  Endocrinology       Date:  2006-11-30       Impact factor: 4.736

8.  Hypocretin Neurotransmission Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced Reinstatement in Rats.

Authors:  Brooke E Schmeichel; Melissa A Herman; Marisa Roberto; George F Koob
Journal:  Biol Psychiatry       Date:  2016-06-16       Impact factor: 13.382

9.  Alkaline sucrose as a solvent for delivery of water-insoluble drugs.

Authors:  V Shah; D Badia; D Kudasheva
Journal:  Folia Microbiol (Praha)       Date:  2009-08-02       Impact factor: 2.099

10.  Inhibition of food intake by PACAP in the hypothalamic ventromedial nuclei is mediated by NMDA receptors.

Authors:  Jon M Resch; Brian Maunze; Kailynn A Phillips; SuJean Choi
Journal:  Physiol Behav       Date:  2014-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.